Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Novo Nordisk,Insulin detemir,Diabetes - type 1 (2nd-line LA insulin treatment),Insulin detemir (Levemir Flexpen),Only if cost neutral or cost saving,Community and Hospital,Alimentary Tract and Metabolism
